Kimberly-Clark Corporation (KMB)
Automate Your Wheel Strategy on KMB
With Tiblio's Option Bot, you can configure your own wheel strategy including KMB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol KMB
- Rev/Share 54.4424
- Book/Share 4.0145
- PB 25.8216
- Debt/Equity 4.8574
- CurrentRatio 0.7735
- ROIC 0.2003
- MktCap 34400443921.0
- FreeCF/Share 7.2725
- PFCF 14.2563
- PE 17.4679
- Debt/Assets 0.3831
- DivYield 0.0482
- ROE 1.7333
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | KMB | Argus | Hold | Buy | -- | $120 | Nov. 13, 2025 |
| Downgrade | KMB | Evercore ISI | Outperform | In-line | -- | $120 | Nov. 4, 2025 |
| Upgrade | KMB | JP Morgan | Underweight | Neutral | -- | $138 | Aug. 4, 2025 |
| Resumed | KMB | Piper Sandler | -- | Overweight | -- | $144 | July 18, 2025 |
| Downgrade | KMB | TD Cowen | Buy | Hold | -- | $145 | Jan. 8, 2025 |
News
4 Highest Yielding Dividend Stocks in the Nasdaq Composite
Published: November 12, 2025 by: 24/7 Wall Street
Sentiment: Positive
Dividend stocks might not sound like an exciting investment in your portfolio, but if you can invest in the right ones, they can generate years of passive income.
Read More
Buy 3 Ideal Dividend Kings Of 24 'Safer' In November's 56
Published: November 10, 2025 by: Seeking Alpha
Sentiment: Positive
The article reviews the November 2025 Dividend Kings, highlighting 56 stocks with long dividend growth records and recent changes to the list. Six Dividend Kings - MO, UVV, HRL, KVUE, CDUAF, UBSI - are currently fairly priced, with annual dividends from $1,000 invested meeting or exceeding share prices. Analyst forecasts suggest top-yielding Kings could deliver net gains of 18.55% to 101.43% by November 2026, with Stepan, H2O America, and National Fuel Gas among the top projections.
Read More
Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction
Published: November 05, 2025 by: MarketBeat
Sentiment: Neutral
On Nov. 3rd, Wall Street rendered a swift and brutal verdict on Kimberly-Clark's NASDAQ: KMB transformative acquisition of Kenvue NYSE: KVUE. While Kenvue's shares climbed over 12%, Kimberly-Clark's stock price dropped more than 14% to a new 52-week low, wiping out approximately $5.8 billion in market value in a single trading session.
Read More
3 Dividend Stocks for November 2025
Published: November 04, 2025 by: Morningstar
Sentiment: Neutral
This month's trio includes two ADRs.
Read More
Kimberly-Clark Corporation (KMB) M&A Call Transcript
Published: November 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation ( KMB ) M&A Call November 3, 2025 8:00 AM EST Company Participants Christopher Jakubik - Investor Relations Contact Michael Hsu - Chairman & CEO Kirk Perry - Interim CEO & Director Sherilyn S. McCoy Nelson Urdaneta - Senior VP & CFO Conference Call Participants Nik Modi - RBC Capital Markets, Research Division Lauren Lieberman - Barclays Bank PLC, Research Division Dara Mohsenian - Morgan Stanley, Research Division Christopher Carey - Wells Fargo Securities, LLC, Research Division Javier Escalante Manzo - Evercore ISI Institutional Equities, Research Division Presentation Operator Good morning.
Read More
Top Stock Movers Now: Amazon, Kenvue, Kimberly-Clark, Beyond Meat, and More
Published: November 03, 2025 by: Investopedia
Sentiment: Positive
Major U.S. equities indexes were mixed Monday afternoon, as tech stocks gained but most other sectors declined. The S&P 500 and Nasdaq rose, while the Dow fell.
Read More
Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger
Published: November 03, 2025 by: The Street
Sentiment: Positive
The deal would bring Huggies, Kleenex, Band-Aid, Neutrogena, and Tylenol under one roof, creating a consumer staples giant. Transcript: Caroline Woods: Big brands and big money - Kimberly-Clark is buying Kenvue in a nearly $50 billion cash and stock deal.
Read More
Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know
Published: November 03, 2025 by: Investopedia
Sentiment: Positive
Kenvue (KVUE) shares skyrocketed in early trading Monday after Kleenex and Cottonelle maker Kimberly-Clark (KMB) said it's buying the Tylenol maker in a $48.7 billion deal.
Read More
Kimberly-Clark to acquire Tylenol-maker Kenvue in $48.7B deal
Published: November 03, 2025 by: Proactive Investors
Sentiment: Positive
Kimberly-Clark Corp (NYSE:KMB, ETR:KMY) announced it will acquire Kenvue (NYSE:KVUE), the maker of Tylenol and other consumer health products, in a cash and stock transaction valued at approximately $48.7 billion. Under the agreement, Kenvue shareholders will receive $3.50 per share in cash plus 0.14625 Kimberly-Clark shares for each Kenvue share, totaling $21.01 per share based on Kimberly-Clark's recent stock price.
Read More
Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal
Published: November 03, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
Kimberly-Clark agreed to buy Kenvue in a deal worth roughly $40 billion in a combination that could create a company with $32 billion in revenue and allow it to surpass Unilever to become the second-biggest seller of health and wellness products after Procter & Gamble. Eric Pfanner reports on Bloomberg Television.
Read More
Tylenol Maker Eyes Best Day Ever on Kimberly-Clark Deal
Published: November 03, 2025 by: Schaeffers Research
Sentiment: Positive
Tylenol maker and former Johnson & Johnson (JNJ) spinoff Kenvue Inc (NYSE:KVUE) is 16.7% higher to trade at $16.74, after Kimberly-Clark Corp (NASDAQ:KMB) agreed to purchase the pharma name for $48.70 billion in cash and stock.
Read More
Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
Published: November 03, 2025 by: New York Post
Sentiment: Positive
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Read More
Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.
Published: November 03, 2025 by: WSJ
Sentiment: Neutral
D.E. Shaw, one of the Tylenol-maker's largest shareholders, stood to lose over $200 million but is now expected to break even on its bet.
Read More
Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal
Published: November 03, 2025 by: Forbes
Sentiment: Neutral
This is a developing story.
Read More
KMB Q3 Earnings Beat Estimates, Sales In Line With the Year-Ago Level
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
KMB's Q3 results highlight steady sales, solid volume gains and cost discipline amid ongoing margin pressures.
Read More
Kimberly-Clark (KMB) Reports Q3 Earnings: What Key Metrics Have to Say
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Kimberly-Clark (KMB) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Kimberly-Clark Corporation (KMB) Q3 2025 Earnings Call Transcript
Published: October 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation ( KMB ) Q3 2025 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Christopher Jakubik - Investor Relations Contact Michael Hsu - Chairman & CEO Russell Torres - President & COO Nelson Urdaneta - Senior VP & CFO Conference Call Participants Javier Escalante Manzo - Evercore ISI Institutional Equities, Research Division Lauren Lieberman - Barclays Bank PLC, Research Division Peter Grom - UBS Investment Bank, Research Division Christopher Carey - Wells Fargo Securities, LLC, Research Division Nik Modi - RBC Capital Markets, Research Division Anna Lizzul - BofA Securities, Research Division Presentation Operator Good day, everyone, …
Read More
KMB to Report Q3 Earnings: Should You Expect a Beat This Time?
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
KMB faces currency and cost pressures ahead of Q3 results, but its Powering Care strategy may offer some relief.
Read More
3 Dividend Stocks to Double Up on Right Now
Published: October 26, 2025 by: The Motley Fool
Sentiment: Positive
Verizon shares have slipped since a new CEO was announced, pumping up its already juicy dividend yield. Realty Income is a REIT that takes great pride in its status as “The Monthly Dividend Company.
Read More
5 Best Dividend Stocks in the Nasdaq Composite
Published: October 20, 2025 by: 24/7 Wall Street
Sentiment: Positive
What's the first thing that springs to mind when someone mentions the Nasdaq Composite?
Read More
100 Barron's Sustainable Dividend Dogs: 4 Ideal October Buys; 9 To Watch; 49 "Safer"
Published: October 15, 2025 by: Seeking Alpha
Sentiment: Positive
Barron's 2025 list of 100 top sustainable companies, ranked by Calvert's ESG criteria, highlights 82 dividend payers ideal for yield-based analysis. Top-ten October 2025 Sustainable dividend-dogs, Regions Financial, Hormel, Air Products, PPG, Interpublic, Keurig Dr. Pepper, Stanley Black & Decker, Robert Half, Avient, and LKQ, ranged 24.25% 49.98% in one-year net-gains. $5k invested in the lowest-priced five of ten top-yield Sustainable companies showed 12.38% more net gain than from $5k invested in all ten per October 10 data.
Read More
Will KMB's Powering Care Strategy & Other Efforts Drive Growth?
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Kimberly-Clark powers growth through innovation, premiumization and its transformative Powering Care strategy.
Read More
Kimberly-Clark Launches Enhanced Global Partnerships to Advance Essential Care for 24 Million Women and Girls
Published: October 09, 2025 by: PRNewsWire
Sentiment: Neutral
DALLAS , Oct. 9, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) is deepening its commitment to advancing essential care for women and girls through four enhanced strategic, charitable partnerships. Through new programs with Baby2Baby, Plan International, Project HOPE, and UNICEF, Kimberly-Clark aims to expand access to life-changing care in Brazil, Peru, China, India, Indonesia, Vietnam, and the United States.
Read More
Trade Tracker: Jenny Harrington buys Millrose Properties and Kimberly-Clark
Published: October 07, 2025 by: CNBC Television
Sentiment: Positive
Jenny Harrington, CEO at Gilman Hill Asset Management, joins CNBC's "Halftime Report" to detail her latest buys.
Read More
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read More
Kimberly-Clark Leverages Innovation and Premiumization to Aid Growth
Published: September 16, 2025 by: Zacks Investment Research
Sentiment: Positive
KMB drives growth through innovation, premiumization and its Powering Care strategy focused on efficiency and consumer engagement.
Read More
Kimberly-Clark Corporation (KMB) Presents At Piper Sandler's Growth Frontiers Conference (Transcript)
Published: September 10, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation (NASDAQ:KMB ) Piper Sandler's Growth Frontiers Conference September 10, 2025 10:30 AM EDT Company Participants Michael Hsu - Chairman & CEO Nelson Urdaneta - Senior VP & CFO Conference Call Participants Michael Lavery - Piper Sandler & Co., Research Division Presentation Michael Lavery Managing Director & Senior Research Analyst All right. Well, thanks, everyone, for coming.
Read More
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: September 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
Kimberly-Clark Corporation (KMB) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
Published: September 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation (NASDAQ:KMB ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 8:15 AM EDT Company Participants Russell Torres - President & COO Michael Hsu - Chairman & CEO Nelson Urdaneta - Senior VP & CFO Conference Call Participants Lauren Lieberman - Barclays Bank PLC, Research Division Presentation Lauren Lieberman MD & Senior Research Analyst Okay. We're going to get started.
Read More
Kimberly-Clark: Portfolio Realignment Supports Upside Case
Published: August 07, 2025 by: Seeking Alpha
Sentiment: Positive
Kimberly-Clark is emerging from a challenging period with improving revenue, rising margins, and a 4% dividend yield, yet remains undervalued by the market. Strategic restructuring, including divesting low-margin businesses and focusing on core personal care, is driving higher quality growth and operational efficiency. Valuation metrics and DCF analysis indicate a 9-14% upside, supporting my Buy rating with a $142 target price and confidence in earnings recovery.
Read More
About Kimberly-Clark Corporation (KMB)
- IPO Date 1980-03-17
- Website https://www.kimberly-clark.com
- Industry Household & Personal Products
- CEO Michael D. Hsu
- Employees 38000